[1]
Mofid, B., Razzaghdoust, A., Ghajari, M., Basiri, A., Fattahi, M.-R., Houshyari, M., Jafari, A. and Taghizadeh-Hesary, F. 2022. The Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant carboplatin in locally advanced bladder cancer. Urology Journal. 19, (Mar. 2022), 6841. DOI:https://doi.org/10.22037/uj.v19i.6841.